"ChristianaCare provides superior, around-the-clock emergency and trauma services to the people of Delaware and the surrounding region. ChristianaCare’s Emergency Department is ranked 24th in the United States."

During the past decade, Christiana Care Health System-Wilmington Hospital conducted 102 clinical trials. In the 10-year time frame, 102 clinical trials started and 65 clinical trials were completed, i.e. on average, 63.7% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 55 clinical trials were completed. i.e. 161.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Christiana Care Health System-Wilmington Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 65 trials, followed by "SWOG Cancer Research Network" with 26 trials sponsored, "Alliance for Clinical Trials in Oncology" with 23 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 15 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 15 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Christiana Care Health System-Wilmington Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 83 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator and "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Christiana Care Health System-Wilmington Hospital" are "HIV Infections" (17 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Invasive Breast Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials) and "Recurrent Breast Carcinoma" (6 trials). Many other conditions were trialed in "Christiana Care Health System-Wilmington Hospital" in a lesser frequency.

Most popular intervention types in "Christiana Care Health System-Wilmington Hospital" are "Drug" (134 trials), "Other" (105 trials), "Biological" (55 trials), "Procedure" (36 trials) and "Radiation" (15 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (55 trials), "Quality-of-Life Assessment" (42 trials), "Questionnaire Administration" (23 trials), "Carboplatin" (21 trials) and "Cisplatin" (17 trials). Other intervention names were less common.

The vast majority of trials in "Christiana Care Health System-Wilmington Hospital" are 143 trials for "All" genders, 26 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Christiana Care Health System-Wilmington Hospital". undefined are not yet recruiting, 34 are recruiting, 77 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 47 completed trials in Christiana Care Health System-Wilmington Hospital, 3 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Christiana Care Health System-Wilmington Hospital, 4 "Phase 1" clinical trials were conducted, 75 "Phase 2" clinical trials and 79 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 14 trials that are defined as “Not Applicable".